Akshaya Gadre
Kalamazoo, MINPI 1518528926
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (40.7%), food and beverage and grants — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Abbott at 51.3% of the total. 2025 is the largest year on record at $23,470, more than ten times the $314 reported in 2022.
Across 201 payments — averaging $163.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$17K
- Medtronic$11K
- Boston Scientific$4K
- Biotronik Inc.$192
- Biosense Webster, Inc.$95
- Edwards Lifesciences$89
- plus $43 from 2 others
What the payments were for
- Grants$8,25025%
- Travel & lodging$13,39141%
- Food & beverage$10,73133%
- Education$5632%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 97 | $16,905 |
| Medtronic | 75 | $11,183 |
| Boston Scientific | 18 | $4,428 |
| Biotronik Inc. | 2 | $192 |
| Biosense Webster, Inc. | 4 | $95 |
| Edwards Lifesciences | 3 | $89 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GALLANT$3,989
- GENERAL - THERAPIES$3,630
- ENSITE PRECISION$3,055
- TACTICATH$2,250
- ASSURITY$2,250
- ENSITE$934
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$638
- RESOLUTE ONYX$474
- ADVISA DR MRI SURESCAN$185
- XIENCE SKYPOINT$172
- Acticor 7 VR-T DX$152
- AGILIS$146
- WATCHMAN Access System$139
- Watchman$111
- Micra$104
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $12,561 |
| JardianceEmpagliflozin | 11 | $7,877 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.